Contracts & Pricing October 15, 2020 Public Law Timeline for 2021, OIG Audit Report, Hot Topics at... 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing September 17, 2020 Additional Drug Reporting for NDA and ANDA Holders, FDA NSDE Structured... 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing August 11, 2020 New Drug Pricing Executive Orders, Changes to 340B 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Patient Access July 27, 2020 Real-Time Data Insights and Actionability All in Single Access-Specific Platform 4 Minute Read Refined patient data aggregation and enhanced inventory analytics. Read more about what's new in the latest ICyte Platform Summer Release.
Contracts & Pricing July 22, 2020 New News From California: Pricing Transparency, State Supplemental Program 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Contracts & Pricing June 19, 2020 The Latest Updates from the Centers for Medicare & Medicaid Services,... 2 Minute Read Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.
Patient Access June 10, 2020 The Four Challenge Cases in Patient Data Mastering 8 Minute Read IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...
Patient Access August 15, 2019 Utilizing AI and Machine Learning to Predict Challenging Patient Cases 3 Minute Read IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...
Patient Access July 12, 2019 Cancellation Reasons Highlight the Opportunity to Proactively Support Stalled Patient Cases 3 Minute Read The quality of status and sub-status data reported by SPs is an ongoing challenge that limits the actionability of data specialty brands have contracted to receive. Clearly, poor data...
